Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
about
The absence of Msh2 alters abelson virus pre-B-cell transformation by influencing p53 mutationInitial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence.Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.Loss of heterozygosity at the Ink4a/Arf locus facilitates Abelson virus transformation of pre-B cellsMink cell focus-forming murine leukemia virus killing of mink cells involves apoptosis and superinfectionAnalysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatmentp53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells.p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.Inhibition of TFII-I-dependent cell cycle regulation by p53.Loss of p53 impedes the antileukemic response to BCR-ABL inhibitionAbsence of p53 complements defects in Abelson murine leukemia virus signalingp19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.Rapid, stabilizing palindrome rearrangements in somatic cells by the center-break mechanism.P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity
P2860
Q28594399-1B3C06D6-22FF-4EBE-B74F-4C87606B748CQ33570433-C9748C7A-DC58-40A1-9713-2F05EDFECAE7Q33810931-B22B9BBE-E289-4EDE-9C3A-C91BC42A9FF0Q33811448-452909F7-7621-4447-9C2C-2041F82F462EQ33842461-531DD091-C528-45B9-A07A-B314E3A9272AQ33850564-3AF0DBC1-742D-44F6-817F-9EEA41D2C6F3Q33887799-96CE55D7-4BBD-4892-84A5-ACE642B4FEE2Q33958575-F2EFB83F-C037-48D6-9FF9-446F8ED41C67Q33961551-E73212F3-DECC-4020-839E-9EA656AA119DQ34230848-9FEBA8A8-2E31-4F0C-A59B-070685D1FF5BQ34585293-CF3A6733-A930-486D-9ACC-6BCD3874B3FEQ34997494-65EC61DB-4379-44FF-A3E6-72C651062F05Q36645083-88C8B5F9-56D7-4891-ADC1-B7D969FE194CQ36845954-16FDB6EC-1850-46F8-AA80-2147CF7E6EB1Q36961499-DE0E8940-E3AC-4E2A-B213-7861497EAC0EQ37010207-94709645-95DB-4807-83E6-C447B09C3C60Q37062358-4702E9FF-01DE-495B-BD28-4DC778460CDDQ39674442-5EA1DA00-FCFC-4EE1-8DEF-DC018D6FB9CE
P2860
Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@en
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@nl
type
label
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@en
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@nl
prefLabel
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@en
Mutation of Tp53 contributes t ...... us-transformed lymphoid cells.
@nl
P2093
P2860
P1433
P1476
Mutation of Tp53 contributes t ...... rus-transformed lymphoid cells
@en
P2093
P2860
P304
P407
P577
1997-11-01T00:00:00Z